Registro:

Referencias:

• Scanlan, M.J., Simpson, A.J., Old, L.J., The cancer/testis genes: Review, standardization, and commentary (2004) Cancer Immun., 4, p. 1
• De Smet, C., Lurquin, C., Lethé, B., Martelange, V., Boon, T., DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter (1999) Mol. Cell. Biol., 19, pp. 7327-7335
• Van Der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van Den Eynde, B., Knuth, A., Boon, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma (1991) Science, 254, pp. 1643-1647
• Sang, M., Lian, Y., Zhou, X., Shan, B., MAGE-A family: Attractive targets for cancer immunotherapy (2011) Vaccine, 29, pp. 8496-8500
• Laduron, S., Deplus, R., Zhou, S., Kholmanskikh, O., Godelaine, D., De Smet, C., Hayward, S.D., De Plaen, E., MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription (2004) Nucleic Acids Res., 32, pp. 4340-4350
• Askew, E.B., Bai, S., Hnat, A.T., Minges, J.T., Wilson, E.M., Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators (2009) J. Biol. Chem., 284, pp. 34793-34808
• Bai, S., Grossman, G., Yuan, L., Lessey, B.A., French, F.S., Young, S.L., Wilson, E.M., Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantation (2008) Mol. Hum. Reprod., 14, pp. 107-116
• Bai, S., He, B., Wilson, E.M., Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction (2005) Mol. Cell. Biol., 25, pp. 1238-1257
• Bai, S., Wilson, E.M., Epidermal-growth-factor-dependentphosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptor (2008) Mol. Cell. Biol., 28, pp. 1947-1963
• Monte, M., Simonatto, M., Peche, L.Y., Bublik, D.R., Gobessi, S., Pierotti, M.A., Rodolfo, M., Schneider, C., MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents (2006) Proc. Natl. Acad. Sci. U.S.A., 103, pp. 11160-11165
• Marcar, L., Maclaine, N.J., Hupp, T.R., Meek, D.W., Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin (2010) Cancer Res., 70, pp. 10362-10370
• Peche, L.Y., Scolz, M., Ladelfa, M.F., Monte, M., Schneider, C., MageA2 restrains cellular senescence by targeting the function of PMLIV/ p53 axis at the PML-NBs (2012) Cell Death Differ., 19, pp. 926-936
• Ladelfa, M.F., Peche, L.Y., Toledo, M.F., Laiseca, J.E., Schneider, C., Monte, M., Tumor-specific MAGE proteins as regulators of p53 function (2012) Cancer Lett., 325, pp. 11-17
• Gure, A.O., Chua, R., Williamson, B., Gonen, M., Ferrera, C.A., Gnjatic, S., Ritter, G., Altorki, N.K., Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer (2005) Clin. Cancer Res., 11, pp. 8055-8062
• Olarte, I., Martinez, A., Ramos-Peñafiel, C., Castellanos-Sinco, H., Zamora, J., Collazo-Jaloma, J., Gutiérrez, M., Miranda, E.I., MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma (2011) Hematology, 16, pp. 368-372
• Ogata, K., Aihara, R., Mochiki, E., Ogawa, A., Yanai, M., Toyomasu, Y., Ando, H., Kuwano, H., Clinical significance of melanoma antigen-encoding gene-1 (MAGE-1) expression and its correlation with poor prognosis in differentiated advanced gastric cancer (2011) Ann. Surg. Oncol., 18, pp. 1195-1203
• Lian, Y., Sang, M., Ding, C., Zhou, X., Fan, X., Xu, Y., Lü, W., Shan, B., Expressions of MAGE-A10 and MAGE-A11 in breast cancers and their prognostic significance: A retrospective clinical study (2012) J. Cancer Res. Clin. Oncol., 138, pp. 519-527
• Sypniewska, R.K., Hoflack, L., Tarango, M., Gauntt, S., Leal, B.Z., Reddick, R.L., Gravekamp, C., Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: Potential for breast cancer therapy (2005) Breast Cancer Res. Treat., 91, pp. 19-28
• Yang, B., O'Herrin, S., Wu, J., Reagan-Shaw, S., Ma, Y., Nihal, M., Longley, B.J., Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo (2007) J. Invest. Dermatol., 127, pp. 267-275
• Yang, B., O'Herrin, S.M., Wu, J., Reagan-Shaw, S., Ma, Y., Bhat, K.M., Gravekamp, C., Longley, B.J., MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines (2007) Cancer Res., 67, pp. 9954-9962
• Lin, Y., Wen, T., Meng, X., Wu, Z., Zhao, L., Wang, P., Hong, Z., Yin, Z., The mouse Mageb18 gene encodes a ubiquitously expressed type i MAGE protein and regulates cell proliferation and apoptosis in melanoma B16-F0 cells (2012) Biochem. J., 443, pp. 779-788
• Jang, S.J., Soria, J.C., Wang, L., Hassan, K.A., Morice, R.C., Walsh, G.L., Hong, W.K., Mao, L., Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis (2001) Cancer Res., 61, pp. 7959-7963
• Pattani, K.M., Soudry, E., Glazer, C.A., Ochs, M.F., Wang, H., Schussel, J., Sun, W., Califano, J.A., MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma (2012) PLoS ONE, 7, p. e45534
• Van Duin, M., Broyl, A., De Knegt, Y., Goldschmidt, H., Richardson, P.G., Hop, W.C., Van Der Holt, B., Sonneveld, P., Cancer testis antigens in newly diagnosed and relapse multiple myeloma: Prognostic markers and potential targets for immunotherapy (2011) Haematologica, 96, pp. 1662-1669
• Krämer, B.F., Schoor, O., Krüger, T., Reichle, C., Müller, M., Weinschenk, T., Hennenlotter, J., Stevanovic, S., MAGED4-expression in renal cell carcinoma and identification of an HLA-A∗25-restrictedMHCclass i ligand from solid tumor tissue (2005) Cancer Biol. Ther., 4, pp. 943-948
• Müller, H., Moroni, M.C., Vigo, E., Petersen, B.O., Bartek, J., Helin, K., Induction of S-phase entry by E2F transcription factors depends on their nuclear localization (1997) Mol. Cell. Biol., 17, pp. 5508-5520
• Taniura, H., Taniguchi, N., Hara, M., Yoshikawa, K., Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1 (1998) J. Biol. Chem., 273, pp. 720-728
• Kuwako, K., Taniura, H., Yoshikawa, K., Necdin-relatedMAGE proteins differentially interact with the E2F1 transcription factor and the p75 neurotrophin receptor (2004) J. Biol. Chem., 279, pp. 1703-1712
• Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J.P., Troalen, F., Harel-Bellan, A., Retinoblastoma protein represses transcription by recruiting a histone deacetylase (1998) Nature, 391, pp. 601-605
• Grandinetti, K.B., David, G., Sin3B: An essential regulator of chromatin modifications at E2F target promoters during cell cycle withdrawal (2008) Cell Cycle, 7, pp. 1550-1554
• Wang, C., Rauscher, F.J., III, Cress, W.D., Chen, J., Regulation of E2F1 function by the nuclear corepressor KAP1 (2007) J. Biol. Chem., 282, pp. 29902-29909
• Zhang, Y., Woodford, N., Xia, X., Hamburger, A.W., Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases (2003) Nucleic Acids Res., 31, pp. 2168-2177
• Zhang, W., Ji, W., Liu, X., Ouyang, G., Xiao, W., ELL inhibits E2F1 transcriptional activity by enhancing E2F1 deacetylation via recruitment of histone deacetylase 1 (2014) Mol. Cell. Biol., 34, pp. 765-775
• Galigniana, M.D., Harrell, J.M., O'Hagen, H.M., Ljungman, M., Pratt, W.B., Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus (2004) J. Biol. Chem., 279, pp. 22483-22489
• Cheng, S., Liu, W., Mercado, M., Ezzat, S., Asa, S.L., Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer (2009) Endocr. Relat. Cancer, 16, pp. 455-466
• Zhou, X., Hao, Q., Liao, J.M., Liao, P., Lu, H., Ribosomal protein S14 negatively regulates c-Myc activity (2013) J. Biol. Chem., 288, pp. 21793-21801
• Lohrum, M.A., Ludwig, R.L., Kubbutat, M.H., Hanlon, M., Vousden, K.H., Regulation of HDM2 activity by the ribosomal protein L11 (2003) Cancer Cell, 3, pp. 577-587
• Donati, G., Brighenti, E., Vici, M., Mazzini, G., Treré, D., Montanaro, L., Derenzini, M., Selective inhibition of rRNA transcription downregulates E2F-1: A new p53-independent mechanism linking cell growth to cell proliferation (2011) J. Cell Sci., 124, pp. 3017-3028
• Su, S., Minges, J.T., Grossman, G., Blackwelder, A.J., Mohler, J.L., Wilson, E.M., Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins (2013) J. Biol. Chem., 288, pp. 24809-24824
• Zhou, F., Zhang, L., Gong, K., Lu, G., Sheng, B., Wang, A., Zhao, N., Gong, Y., LEF-1 activates the transcription of E2F1 (2008) Biochem. Biophys. Res. Commun., 365, pp. 149-153
• Fedele, M., Pierantoni, G.M., Visone, R., Fusco, A., E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression (2006) Cell Div., 1, p. 17
• Berkovich, E., Ginsberg, D., Ras induces elevation of E2F-1 mRNA levels (2001) J. Biol. Chem., 276, pp. 42851-42856
• Matsumura, I., Tanaka, H., Kanakura, Y., E2F1 and c-Myc in cell growth and death (2003) Cell Cycle, 2, pp. 333-338
• Stanelle, J., Pützer, B.M., E2F1-induced apoptosis: Turning killers into therapeutics (2006) Trends Mol. Med., 12, pp. 177-185
• Iaquinta, P.J., Lees, J.A., Life and death decisions by the E2F transcription factors (2007) Curr. Opin. Cell Biol., 19, pp. 649-657
• Hallstrom, T.C., Nevins, J.R., Jab1 is a specificity factor for E2F1-induced apoptosis (2006) Genes Dev., 20, pp. 613-623
• Lu, H., Liang, X., Issaenko, O.A., Hallstrom, T.C., Jab1/CSN5 mediates E2F dependent expression of mitotic and apoptotic but notDNA replication targets (2011) Cell Cycle, 10, pp. 3317-3326
• Hallstrom, T.C., Mori, S., Nevins, J.R., An E2F1-dependent gene expression program that determines the balance between proliferation and cell death (2008) Cancer Cell, 13, pp. 11-22
• Engelmann, D., Pützer, B.M., Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance (2010) Drug Resist. Updat., 13, pp. 119-131
• Lee, T.J., Yao, G., Bennett, D.C., Nevins, J.R., You, L., Stochastic E2F activation and reconciliation of phenomenological cell-cycle models (2010) PLoS Biol., 8, p. e1000488
• Imai, T., Horiuchi, A., Shiozawa, T., Osada, R., Kikuchi, N., Ohira, S., Oka, K., Konishi, I., Elevated expression of E-cadherin and β-, β-, and β-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas (2004) Hum. Pathol., 35, pp. 1469-1476
• Hans, C.P., Weisenburger, D.D., Vose, J.M., Hock, L.M., Lynch, J.C., Aoun, P., Greiner, T.C., Armitage, J.O., A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival (2003) Blood, 101, pp. 2363-2367
• Novy, M., Pohn, R., Andorfer, P., Novy-Weiland, T., Galos, B., Schwarzmayr, L., Rotheneder, H., EAPP, a novel E2F binding protein that modulates E2F-dependent transcription (2005) Mol. Biol. Cell, 16, pp. 2181-2190
• Andorfer, P., Rotheneder, H., EAPP: Gatekeeper at the crossroad of apoptosis and p21-mediated cell-cycle arrest (2011) Oncogene, 30, pp. 2679-2690
• Demetrius, L., Of mice and men: When it comes to studying ageing and the means to slow it down, mice are not just small humans (2005) EMBO Rep., 6, pp. S39-44
• Wen, C.J., Xue, B., Qin, W.X., Yu, M., Zhang, M.Y., Zhao, D.H., Gao, X., Li, C.J., HNRAGE, a human neurotrophin receptor interacting MAGE homologue, regulates p53 transcriptional activity and inhibits cell proliferation (2004) FEBS Lett., 564, pp. 171-176

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------